title: My personal highlights of ESMO 2016.
abstract: Results of several clinically relevant studies were presented at the 2016 Annual Meeting of the European Society of Medical Oncology (ESMO). This article summerizes the personal highlights of three medical oncologists in their respective areas of expertise.
authors.affiliation: Department of Oncology, Sanador Hospital, Bucharest, Romania.
authors.forename: M
authors.initials: M
authors.lastname: Dediu
authors.affiliation: Department of Medicine, Division of Oncology, Medical University of Graz, Graz, Austria.
authors.forename: A
authors.initials: A
authors.lastname: Gerger
authors.affiliation: Department of Haematology and Medical Oncology, Wilhelminenspital Vienna, Vienna, Austria.
authors.forename: N
authors.initials: N
authors.lastname: Zojer
authors.affiliation: Department of Medicine 1, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090 Austria.
authors.forename: R
authors.identifier: 0000-0002-4384-6917
authors.initials: R
authors.lastname: Bartsch
keywords: ESMO 2016 meeting; Highlights; Immunotherapy; Niraparib; Ribociclib